Evidence map›Paper›PMID 32425382›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2020

Higher Level of Peripheral Blood CD34 Positive Cells Presented with Unfavorable Prognosis in Intermediate-Low Risk Acute Promyelocytic Leukemia.

Cuiling Zhang, Haibo Dong, Yipeng Lin, Peipei Xu, Rongfu Zhou, Hui Zeng

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Cuiling Zhang1Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, 210093 People's Republic of China.
Haibo Dong1Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, 210093 People's Republic of China.
Yipeng Lin1Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, 210093 People's Republic of China.
Peipei Xu1Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, 210093 People's Republic of China.
Rongfu Zhou1Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, 210093 People's Republic of China.
Hui Zeng1Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, 210093 People's Republic of China.
Nanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our previous work has demonstrated that some acute promyelocytic leukemia (APL) patients had significantly elevated circulating CD34+ cell count (≥ 10 × 10

Indexed as

Acute promyelocytic leukemiaCirculating CD34+ cell countPeripheral bloodPrognostic factorProgression-free survival

Identifiers

PMID32425382
PMCPMC7229103
OpenAlexW2994695689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.